|
OUR BLOOD-BRAIN BARRIER MODEL (2/2)
2- Transport experiments using the in vitro blood-brain
barrier.
On the day of the experiments, Ringer-HEPES (NaCl 150mM, KCl 5.2mM,
CaCl2 2.2mM, MgCl2 6H2O 0.2mM, NaHCO3 6mM, HEPES 5mM, glucose 2.8mM)
is added to the lower compartment (abluminal side) of a six-well
plate (2.5 ml per well). One filter containing a confluent monolayer
of endothelial cells is transferred in the first well of the six-well
plate containing Ringer-HEPES.
A 1.5 ml Ringer-HEPES volume containing labelled drugs is placed
in the upper compartment (luminal side). At 10, 15, 20, 30, 45 and
60 min after addition of the test compound, the insert is transferred
to another well of the six-well to minimize the possible passage
of substances from the lower to the upper compartment.
Figure 3 : Schema of the permeability studies.

Triplicate monolayers and triplicate filters coated
with collagen only are assayed for each labelled drug.
Incubations are performed on a rocking platform at 37°C.
At the end of each incubation period, two aliquots (500 µl
) of abluminal and luminal liquid were performed.
4-Analytical procedures.
a) Radioactive analysis.
Radioactivity is determined in representative samples from each
lower compartiment (3 filters) and from the initial solution containing
[14C] or[3H] -labelled drug.
|
Lower compartment
(abluminal side) :
|
Aliquots of 500 µl are added directly
to liquid scintillant and measured by liquid scintillation
counting
|
|
Initial solution
(luminal side):
|
Aliquots of 20 µl are added directly
to liquid scintillant and measured by liquid scintillation
counting
|
|
Endothelial and astrocytes cells :
|
The total radioactivity in the filter and
endothelial cells have been measured by liquid scintillation
counting, removing the filter from his support.
|
b) HPLC analysis
Because most of the molecules are not radiolabelled, the concentrations
were performed by HPLC.
5- Data analysis: Endothelial permeability coefficient.
To obtain a concentration-dependant transport parameter, the clearance
principle is used. For each time, the increment in cleared volume
between successive sampling events is calculated by dividing the
amount of transported solute by the donor chamber concentration.
The total volume cleared at each point is calculated by summing
the incremental cleared volumes up to the given time point :
[C]A
X VA
Clearance ( l) = -----------------
[C]L
where [C]L is the initial luminal tracer concentration, [C]A the
abluminal tracer concentration, and VA the volume of the abluminal
chamber.
During the 60-min experiment, the clearance volume increases linearly
with time. The average volume cleared is plotted versus time, and
the slope is estimated by linear regression analysis to give the
mean and the SE to the estimate. The slope of the clearance curves
for the coculture is denoted PSt, where PS is the permeability x
surface area product (in microliters per minute). The slope of the
clearance curve for the control filter is denoted PSf.
The PS value for the endothelial monolayer (PSe) was calculated
from:
1
1
1
--------- = ------------ - ------------
Pse
PSt
PSf
The PSe values were divided by the surface area of the Millicell-PC
(4.2 cm2) to generate the endothelial permeability coefficient (Pe,
in centimeters per minute).
See the related publications
<<< Previous Page
|